XLY.V - Auxly Cannabis Group Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.88
+0.01 (+1.15%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.87
Open0.88
Bid0.87 x 0
Ask0.89 x 0
Day's Range0.84 - 0.91
52 Week Range0.73 - 1.45
Volume3,459,766
Avg. Volume2,015,460
Market Cap500.799M
Beta17.75
PE Ratio (TTM)N/A
EPS (TTM)-0.11
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.28
  • GlobeNewswire21 hours ago

    Auxly Announces Acquisition of Leading Canadian Contract Research Organization KGK Science

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that it has entered into a share purchase agreement (the “Share Purchase Agreement”) with KGK Science Inc. (“KGK”) to acquire all of the issued and outstanding shares of KGK (the “KGK Shares”) for total consideration of $12,300,000 payable in cash and common shares of the Company. KGK is a leading health and wellness focused private contract research organization based in London, Ontario, and the Company expects to leverage KGK’s expertise and research abilities to further the Company’s product development efforts through collaboration with the Company’s wholly owned subsidiary, Dosecann Inc. (“Dosecann”).

  • GlobeNewswire8 days ago

    Auxly Announces Product Strategy Update and World-Class Additions to Dosecann's Management Team

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to provide an update on the product strategy of the Company’s wholly owned subsidiary, Dosecann Inc. (“Dosecann”), as well as a number of strategic additions to the management team of Dosecann. Dosecann, Auxly’s cornerstone midstream asset that is Canada’s largest cannabis specific “Licensed Dealer”, is positioned to play a significant role as a leading research, product development, extraction, formulation and consumer packaged goods manufacturing center in the Canadian cannabis industry with its 42,000 square foot purpose-built facility in Charlottetown, PEI. As previously announced, Dosecann has successfully obtained a Dealer’s Licence for Controlled Drugs and Substances (the “Licence”) from Health Canada and has commenced operations related to the creation of value-added cannabis products, as permitted by the Licence and applicable laws.

  • GlobeNewswire9 days ago

    Auxly Announces Strategic Partnership With Cannabis OneFive

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that it has entered into a strategic partnership with Cannabis OneFive, Inc. (“C15”), a provider of quality management and document control software systems for the cannabis industry. Auxly’s wholly-owned subsidiary, Dosecann Inc. (“Dosecann”), will become a lead subscriber of C15’s software, and the Company expects the C15 software to be deployed at other Auxly facilities. In connection with the strategic partnership, the Company has entered into a share exchange agreement (the “Share Exchange Agreement”) with C15.

  • GlobeNewswire13 days ago

    Auxly Announces Receipt of Dealer’s Licence for Dosecann Facility

    Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") is pleased to announce that the Company’s wholly-owned subsidiary, Dosecann Inc. (“Dosecann”), has successfully obtained a Dealer’s Licence for Controlled Drugs and Substances (the “Licence”) from Health Canada pursuant to the Narcotics Control Regulations for Dosecann’s purpose built 42,000 square foot facility located in Charlottetown, PEI.

  • GlobeNewswire21 days ago

    Auxly Congratulates Strategic Partner Inner Spirit on Initial Public Offering and Files Early Warning Report

    Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly"), is pleased to announce that its strategic down-stream retail partner Inner Spirit Holdings Ltd. ("Inner Spirit"), has received all of the necessary exchange and regulatory approvals to commence trading publicly on the Canadian Securities Exchange under the symbol “ISH” as of August 1, 2018. Pursuant to the requirements of National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and applicable Canadian securities legislation, Auxly announces that in connection with the completion by Inner Spirit of its initial public offering on July 31, 2018 (the "IPO"), Auxly has acquired 7,058,824 units of Inner Spirit, with each unit consisting of one common share of Inner Spirit (each a "Common Share") and one-half of one Common Share purchase warrant of Inner Spirit (for a total of 3,529,412 warrants) in consideration for an aggregate purchase price of $1,058,823.60, with each warrant entitling the holder to purchase one Common Share at an exercise price of $0.30 per Common Share for a period of 24 months from the date of issuance.

  • Inner Spirit Holdings Closes Initial Public Offering, Newstrike Transaction and Auxly Private Placements and Announces Commencement of Trading on the Canadian Securities Exchange
    CNW Group21 days ago

    Inner Spirit Holdings Closes Initial Public Offering, Newstrike Transaction and Auxly Private Placements and Announces Commencement of Trading on the Canadian Securities Exchange

    CALGARY , July 31, 2018 /CNW/ - Inner Spirit Holdings Ltd. ("Inner Spirit" or "the Company"), is pleased to announce that it has closed its initial public offering (the "IPO"). The Company closed on the maximum gross proceeds under the IPO of $3,750,000 and issued 25,000,000 units of Inner Spirit (the "Units"). Each Unit consists of one common share in the capital of the Company (each, a "Common Share") and one-half of one Common Share purchase warrant (each whole Common Share purchase warrant, a "Unit Warrant").

  • CNW Group22 days ago

    High Tide Enters into Multiple MOUs to Supply its Saskatchewan Wholesale Operations

    CALGARY , July 30, 2018 /CNW/ - High Tide Ventures Inc. ("High Tide" or the "Company") today announced that it has recently entered into multiple non-binding memorandums of understanding ("MOUs") to supply the Saskatchewan market on a wholesale basis for a combined total of up to 9,500 kilograms of cannabis products over the next year, as available.  High Tide is in the process of becoming a licensed wholesaler of cannabis products in the province of Saskatchewan .  The MOUs are with FV Pharma Inc. ("FV Pharma"), Maple Leaf Green World Inc. ("Maple Leaf"), Sundial Growers Inc. ("Sundial") and The Supreme Cannabis Company, Inc. ("Supreme").

  • GlobeNewswire26 days ago

    Auxly Announces Listing of Warrants

    VANCOUVER, British Columbia, July 27, 2018-- Auxly Cannabis Group Inc. is pleased to announce that it has received the approval of the TSX Venture Exchange for the listing of 32,200,000 common share purchase ...

  • GlobeNewswirelast month

    Auxly Announces Issuance of Sales Licence for Kolab Project and Provides Update on Saskatchewan Retail Strategy

    Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") is pleased to announce that its wholly-owned subsidiary, Kolab Project Inc. ("Kolab" or “Kolab Project”), has received its sales licence from Health Canada, pursuant to the Access to Cannabis for Medical Purposes Regulations. Kolab will source the best cannabis products from the entire Auxly cultivation platform and through partnerships with acclaimed growers from around the world. Among these will be Kolab’s facility in Carleton Place, Ontario, where the second phase of construction has been completed and is expected to be commissioned for cultivation in the coming months.

  • FSD Pharma Enters Into Saskatchewan Wholesale Supply MOU of up to 5,000 Kilograms With High Tide Ventures
    CNW Grouplast month

    FSD Pharma Enters Into Saskatchewan Wholesale Supply MOU of up to 5,000 Kilograms With High Tide Ventures

    TORONTO , July 19, 2018 /CNW/ - FSD Pharma Inc. ("FSD Pharma") (HUGE.CN) (FSDDF) today announced that its wholly-owned subsidiary, FV Pharma Inc. ("FV Pharma") has entered into a non-binding memorandum of understanding ("MOU") with High Tide Ventures Inc. ("High Tide") dated July 18, 2018 to supply the Saskatchewan market on a wholesale basis with up to 5,000 kilograms of cannabis products over the next year when available. FSD Pharma is working together with Auxly (formerly Cannabis Wheaton Income Corp.) (XLY.V) to achieve its mission to develop the largest hydroponic indoor cannabis cultivation facility in Cobourg, Ontario, Canada .

  • GlobeNewswirelast month

    Auxly Congratulates Streaming Partner CannTx Life Sciences on Obtaining Cultivation Licence

    Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") is pleased to announce that Auxly’s streaming partner, CannTx Life Sciences Inc. (“CannTx”), has been granted a cultivation licence for its production facility in Puslinch, Ontario pursuant to the Access to Cannabis for Medical Purposes Regulations. Chuck Rifici, Chairman and CEO of Auxly commented, "We want to congratulate the team at CannTx on obtaining their cultivation licence! This represents a major milestone and achievement for CannTx and for the broader Auxly business strategy. Pursuant to the definitive agreement entered on December 22, 2017, the Company has provided CannTx with $5,000,000 related to the initial costs for the phase I construction of CannTx's 30,000 square foot facility.

  • GlobeNewswirelast month

    Auxly Announces Director Resignation

    Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") has announced today that following his appointment as Chief Executive Officer of a federal agency, Invest in Canada, Ian McKay has resigned as a director of the Company’s Board of Directors. The Company has initiated a search for a new director to replace Mr. McKay. Chuck Rifici, Chairman and Chief Executive Officer of Auxly Cannabis Group commented, “On behalf of the Board of Directors and the Auxly team, I'd like to thank Ian for his valuable guidance and support over the past year.

  • OTC Markets Group Welcomes Auxly Cannabis Group to OTCQX
    PR Newswire2 months ago

    OTC Markets Group Welcomes Auxly Cannabis Group to OTCQX

    NEW YORK , July 6, 2018 /PRNewswire/ --  OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Auxly Cannabis Group Inc . (TSX-V: XLY; ...

  • GlobeNewswire2 months ago

    Auxly Announces Upgrade on OTC Markets to OTCQX

    VANCOUVER, British Columbia, July 06, 2018-- Auxly Cannabis Group Inc. is pleased to announce that effective today, July 6, 2018, the Company's common shares on the OTC Markets will begin trading on the ...

  • FSD Pharma Inc. announces $55 million dollar indoor cannabis grow partnership expansion at its Cobourg facility
    CNW Group2 months ago

    FSD Pharma Inc. announces $55 million dollar indoor cannabis grow partnership expansion at its Cobourg facility

    TORONTO , July 3, 2018 /CNW/ - FSD Pharma Inc. ("FSD" or the "Company") (HUGE.CN) is pleased to provide an update on the progress of the joint venture between its wholly-owned subsidiary, FV Pharma Inc. ("FV Pharma) and Auxly Cannabis Group Inc. (TSX.V – XLY) ("Auxly"). The first phase of the buildout of the FV Pharma facility (the "Facility") in Cobourg, Ontario has been approved in an updated construction and development budget provided by Auxly. Of the current 620,000 square feet of building space available, 220,000 square feet will be developed and fully funded.

  • GlobeNewswire2 months ago

    Auxly Provides Development Update on the FV Pharma Joint Venture

    Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") is pleased to provide the following construction development update on the joint venture with FV Pharma Inc. (“FV Pharma”), a wholly-owned subsidiary of FSD Pharma Inc. (CSE:HUGE) at the former Kraft food-production facility (the “Facility”) located in Cobourg, Ontario. The Facility hosts an initial 620,000 square feet of building space, a portion of which is currently licensed for cultivation pursuant to the Access to Cannabis for Medical Purposes Regulations, and can support additional expansion capacity of approximately 3,800,000 square feet on the existing property, pending completion of all phases of the project. Pursuant to the updated and approved construction budget, Auxly will contribute $55,000,000 to develop the first phase of the project.

  • GlobeNewswire2 months ago

    Auxly Announces Signing of Definitive Joint Venture Agreement With Peter Quiring to Build State-Of-The-Art 1.4 Million Square Foot Greenhouse

    Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") is pleased to announce that further to its previously announced transaction on February 16, 2018, the Company has entered into a definitive joint venture agreement with Peter Quiring, one of Canada’s largest greenhouse builders and operators, via a newly formed subsidiary (the "JVCo"), to develop, construct and operate a fully-automated, state-of-the-art, purpose-built greenhouse for cannabis cultivation in Leamington, Ontario (the "Facility"). Pursuant to the agreement, Mr. Quiring, through South Essex Fabricating, will be responsible for the design, construction and operation of the Facility, and the Company will be responsible for funding the project and assisting JVCo in obtaining its ACMPR license for the cultivation and sale of cannabis (the “License”) by providing JVCo with all of the resources and expertise necessary to achieve the License.